KORU Medical Systems (NASDAQ:KRMD) Price Target Raised to $5.00

KORU Medical Systems (NASDAQ:KRMD - Get Free Report) had its price target increased by research analysts at Lake Street Capital from $4.00 to $5.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a "buy" rating on the stock. Lake Street Capital's price objective suggests a potential upside of 22.85% from the stock's previous close.

KRMD has been the subject of a number of other research reports. Piper Sandler boosted their target price on KORU Medical Systems from $3.00 to $3.50 and gave the stock an "overweight" rating in a report on Thursday, November 14th. Craig Hallum increased their price objective on shares of KORU Medical Systems from $4.00 to $5.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. Finally, Canaccord Genuity Group lifted their target price on shares of KORU Medical Systems from $3.00 to $4.00 and gave the company a "buy" rating in a report on Thursday, November 14th. Four research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, KORU Medical Systems currently has a consensus rating of "Buy" and an average target price of $4.30.

KORU Medical Systems Trading Up 3.0 %

Shares of NASDAQ:KRMD traded up $0.12 during trading on Tuesday, reaching $4.07. The stock had a trading volume of 85,278 shares, compared to its average volume of 104,272. KORU Medical Systems has a fifty-two week low of $1.98 and a fifty-two week high of $4.60. The business has a fifty day moving average price of $3.75 and a 200-day moving average price of $2.95. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01. The stock has a market cap of $186.56 million, a P/E ratio of -16.28 and a beta of 0.45.

Institutional Trading of KORU Medical Systems

Hedge funds have recently made changes to their positions in the stock. XTX Topco Ltd acquired a new position in KORU Medical Systems during the 3rd quarter worth $34,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in KORU Medical Systems in the second quarter worth about $107,000. Connor Clark & Lunn Investment Management Ltd. raised its position in shares of KORU Medical Systems by 77.7% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company's stock valued at $168,000 after acquiring an additional 26,860 shares in the last quarter. Empire Financial Management Company LLC acquired a new position in KORU Medical Systems in the third quarter worth $259,000. Finally, Geode Capital Management LLC lifted its position in shares of KORU Medical Systems by 6.5% in the 3rd quarter. Geode Capital Management LLC now owns 462,128 shares of the company's stock worth $1,262,000 after buying an additional 28,323 shares during the last quarter. Institutional investors and hedge funds own 58.60% of the company's stock.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.